
The Mesothelioma Center News – Page 2
-
Asbestos Exposure & BansThe U.S. Environmental Protection Agency proposed a potentially historic ban April 5 that would prohibit all current uses of chrysotile asbestos. Chrysotile is…
-
Legislation & Litigation
Senate Passes Asbestos Awareness Resolution, Inches Closer to Ban
The U.S. Senate unanimously passed its annual National Asbestos Awareness Week resolution, inching closer to long-awaited, much-anticipated legislation to ban the toxic substance. The…April 4, 2022 -
Asbestos Exposure & Bans
Past Asbestos Testing on Inmates Could Affect J&J Talc Lawsuits
Johnson & Johnson funded a study more than 50 years ago at a Philadelphia prison that injected asbestos fibers into a small number…March 16, 2022 -
Legislation & Litigation
$36.5 Million Verdict Could Change Asbestos Litigation in Libby, Montana
A Montana District Court jury recently delivered a $36.5 million verdict in a bellwether case that is expected to significantly change the landscape of…March 3, 2022 -
Legislation & Litigation
Johnson & Johnson’s Talc Bankruptcy Plan Approved
Much to the ire of plaintiff attorneys across the country, a federal judge in New Jersey granted approval for Johnson & Johnson to…March 1, 2022 -
Research & Clinical Trials
Mesothelioma Clinical Trial Matches Treatment to Genetic Profiles
Scientists at the University of Leicester in the United Kingdom recently published phase 2 clinical trial results involving abemaciclib, a new genetic therapy for…February 28, 2022 -
Research & Clinical Trials
NCI Moving Closer to More Effective Treatment for Pleural Mesothelioma
A research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma.February 1, 2022 -
Asbestos Exposure & Bans
FDA Looks at Stricter Testing for Asbestos in Talc
The U.S. Food and Drug Administration recently moved a step closer to a much-needed, stricter standardization of testing for the presence of toxic…January 18, 2022 -
Treatment & Doctors
Mesothelioma Specialty Centers Factor in 2021 Best Hospital Rankings
University of Texas MD Anderson Cancer Center in Houston is No. 1 for the seventh consecutive year on the prestigious U.S. News &…January 12, 2022 -
Research & Clinical Trials
NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
The National Cancer Institute has opened a promising clinical trial aimed at increasing the effectiveness of immunotherapy treatment for patients with unresectable malignant…January 4, 2022